Ahn-Gook Pharmaceutical Co., Ltd. - Product Pipeline Review - Q4 2010

Global Markets Direct, December 2010, Pages: 32

Ahn-Gook Pharmaceutical Co., Ltd. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Ahn-Gook Pharmaceutical Co., Ltd. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Ahn-Gook Pharmaceutical Co., Ltd. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Ahn-Gook Pharmaceutical Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Ahn-Gook Pharmaceutical Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Ahn-Gook Pharmaceutical Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Ahn-Gook Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Ahn-Gook Pharmaceutical Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Ahn-Gook Pharmaceutical Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Ahn-Gook Pharmaceutical Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Ahn-Gook Pharmaceutical Co., Ltd. and identify potential opportunities in those areas.

List of Tables
List of Figures
Ahn-Gook Pharmaceutical Co., Ltd. Snapshot
Ahn-Gook Pharmaceutical Co., Ltd. Overview
Key Information
Key Facts
Ahn-Gook Pharmaceutical Co., Ltd. – Research and Development Overview
Key Therapeutic Areas
Ahn-Gook Pharmaceutical Co., Ltd. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Ahn-Gook Pharmaceutical Co., Ltd. – Pipeline Products Glance
Ahn-Gook Pharmaceutical Co., Ltd. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Ahn-Gook Pharmaceutical Co., Ltd. Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Ahn-Gook Pharmaceutical Co., Ltd.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Ahn-Gook Pharmaceutical Co., Ltd. – Drug Profiles
AG NPP709 Syrup
Product Description
Mechanism of Action
R&D Progress
AG1321001SY
Product Description
Mechanism of Action
R&D Progress
AG PPC709
Product Description
Mechanism of Action
R&D Progress
AG SCT101
Product Description
Mechanism of Action
R&D Progress
AG SDT102
Product Description
Mechanism of Action
R&D Progress
AG SPT201
Product Description
Mechanism of Action
R&D Progress
AG NCA805
Product Description
Mechanism of Action
R&D Progress
AG NDP803
Product Description
Mechanism of Action
R&D Progress
AG NDT802
Product Description
Mechanism of Action
R&D Progress
AG SFT103
Product Description
Mechanism of Action
R&D Progress
Ahn-Gook Pharmaceutical Co., Ltd. – Pipeline Analysis
Ahn-Gook Pharmaceutical Co., Ltd. – Pipeline Products by Therapeutic Class
Ahn-Gook Pharmaceutical Co., Ltd. – Pipeline Products by Route of Administration
Ahn-Gook Pharmaceutical Co., Ltd. - Dormant Projects
Ahn-Gook Pharmaceutical Co., Ltd. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• Education Services - Global Strategic Business Report
• Charter Schools - Global Outlook
• Generic Defense Strategies: Lifecycle Management Strategies to Maximize Revenue in the Face of Growing Generic Competition
• The Future of the Biodefense Industry: Regulation, Funding Opportunities & Company Profiles
• Aerospace and Defense Industry - Global Outlook